Announced yesterday September 23, 2011 by Tufts University School of Medicine (TUSM), was the identification of the cellular origins of breast cancer that might lead to earlier diagnosis and more efficient management of the disease.
New research led by Charlotte Kuperwasser of TUSM has determined that common forms of breast cancer originate from breast cells known as luminal epithelial cells while rarer forms of breast cancer, such as metaplastic carcinomas, originate from basal epithelial cell types.
“For the past several decades, most research efforts have been focused on discovering cancer-causing genes in hope that this information might help us discover better treatments for breast cancer. While these efforts have led to successes in treating some common forms of breast cancer, they have not provided us with information regarding where breast cancer originates and in particular, the origins of rare forms of metaplastic breast cancers for which the best course of treatment has not yet been determined,” said Kuperwasser, Ph.D., associate professor in the department of anatomy and cellular biology, Tufts University School of Medicine, and a member of the genetics and cell, molecular & developmental program faculties at the Sackler School of Graduate Biomedical Sciences at Tufts and the Molecular Oncology Research Institute (MORI) at Tufts Medical Center.
In light of this, the research team chose to study the two major types of cells in the human breast, those that line the ducts and produce milk (luminal cells) and those that surround the ductal cells and contract to move the milk from the ducts (basal/myoepithelial cells) to determine whether they might form different types of breast cancers.
“We found that when basal/myoepithelial breast cells become cancerous they no longer resemble breast tissue; instead they look more like cells of the skin and form rare metaplastic breast cancers. In contrast, when luminal breast cells become cancerous, they retain the structure and molecular features of more common types of breast cancers,” said first author Patricia Keller, Ph.D., post-doctoral associate in the anatomy and cellular biology department at TUSM and a member of the Kuperwasser lab and MORI.
The researchers introduced cancer-causing genes into healthy breast cells obtained from breast reduction surgeries. Using specialized markers, they were able to isolate different types of normal breast cells and evaluate how they behaved as they became cancerous in a mouse model.
“By understanding more about the cellular beginnings of cancer, we can direct our research toward investigating preventive methods and possibly even developing new therapies,” said Kuperwasser.
Source: Tufts University
Follow me on Facebook, Twitter and Myspace! Click Subscribe to receive articles on Women’s Issues topics via email! Questions about this article or simply want to contact this writer? Send an email to email@example.com.
The National Director of Truckers Against Trafficking, Kendis Paris, joins Y.P. Mazzulo and co-hosts, Debbie Barth and Joyce Bagley on October 1st, On The Grid…where Real Life Happens!
©2011 Yvonne P. Mazzulo, All rights reserved. No part of this article may be reproduced without prior permissions from the author or Clarity Digital Group LLC d/b/a knotmove.com.